LaQuisa Hill (@hilllaquisa) 's Twitter Profile
LaQuisa Hill

@hilllaquisa

ID: 1018600253212131329

calendar_today15-07-2018 20:56:39

74 Tweet

179 Followers

138 Following

Max Mamonkin (@maxmamonkin) 's Twitter Profile Photo

Encouraging results of two parallel studies of CD30 CAR-T in patients with r/r Hodkins Lymphoma performed at Baylor and UNC. CR rate 59% in the cohorts that received fludarabine-based preconditioning ascopubs.org/doi/abs/10.120…

LaQuisa Hill (@hilllaquisa) 's Twitter Profile Photo

Excited and honored to moderate one of the #GVHD oral abstracts sessions with Shernan Holtan MD from UMN Medical School tomorrow!! Join us at 2:30pm CST! Looking forward to hearing some great presentations. #TCTM21 ASTCT CIBMTR

Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx (@carttherapy) 's Twitter Profile Photo

Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We... : The Cancer Journal journals.lww.com/journalppo/Abs… #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy ASTCT

Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We... : The Cancer Journal journals.lww.com/journalppo/Abs… 
#CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS  #CARTcells #CellTherapy 
<a href="/ASTCT/">ASTCT</a>
LaQuisa Hill (@hilllaquisa) 's Twitter Profile Photo

Please ignore the recent tweet regarding Ray Bans for sale - my account was hacked!! 🥴🥴 I think I have rectified it now. Apologies!

IOYIF (@ioyiforum) 's Twitter Profile Photo

Dr. LaQuisa Hill from BCMHouston and Houston Methodist presented her work evaluating the safety and efficacy signals of CD5 CAR T-cells in the setting of relapsed/refractory T-cell lymphomas. #IOYIF21 LaQuisa Hill #celltherapy #CART

Dr. LaQuisa Hill from <a href="/bcmhouston/">BCMHouston</a> and <a href="/MethodistHosp/">Houston Methodist</a> presented her work evaluating the safety and efficacy signals of CD5 CAR T-cells in the setting of relapsed/refractory T-cell lymphomas. #IOYIF21 <a href="/HillLaQuisa/">LaQuisa Hill</a> #celltherapy #CART
Max Mamonkin (@maxmamonkin) 's Twitter Profile Photo

Back in 2017, I had an absolute blast at the IOYIF discussing preclinical development of CD5 CARTs for T-cell malignancies. It was an amazing meeting! Fast forward to 2021, my stellar colleague LaQuisa Hill is showing clinical results of CD5 CAR T-cells in her patients with PTCL

LaQuisa Hill (@hilllaquisa) 's Twitter Profile Photo

What a fantastic past 48 hours!! Congrats to all the awardees but especially my colleagues at BCMHouston Center for Cell and Gene Therapy Drs. Valentina Hoyos Valentina Hoyos Velez, MD and Katie McKenna on their first place wins!!!🥇 Phenomenal work ladies!! IOYIF #IOYIF21

What a fantastic past 48 hours!!  Congrats to all the awardees but especially my colleagues at <a href="/bcmhouston/">BCMHouston</a> <a href="/CAGTHouston/">Center for Cell and Gene Therapy</a> Drs. Valentina Hoyos <a href="/tinahoyosv/">Valentina Hoyos Velez, MD</a> and Katie McKenna on their first place wins!!!🥇 Phenomenal work ladies!! <a href="/IOYIForum/">IOYIF</a> #IOYIF21
LaQuisa Hill (@hilllaquisa) 's Twitter Profile Photo

Thank you again IOYIF for the opportunity to participate in this years forum! So inspiring to be among such brilliant minds and learning about some of the amazing work being done in the field! Shout to the BCMHouston Center for Cell and Gene Therapy crew for strong representation!! #IOYIF21

Thank you again <a href="/IOYIForum/">IOYIF</a> for the opportunity to participate in this years forum! So inspiring to be among such brilliant minds and learning about some of the amazing work being done in the field! Shout to the <a href="/bcmhouston/">BCMHouston</a> <a href="/CAGTHouston/">Center for Cell and Gene Therapy</a> crew for strong representation!! #IOYIF21
Teddy Mitrosilis (@tmitrosilis) 's Twitter Profile Photo

1. Build your Memory Log Open a document. Title it “Memory Log.” Add one thing you want to remember from today. • A story • A moment • A conversation Anything. Doing this will inspire you to create more memories tomorrow. Over time, it’ll also become a cherished gift.

Max Mamonkin (@maxmamonkin) 's Twitter Profile Photo

Based on these studies, we started a Phase I clinical trial (NCT03690011) in patients with r/r T-ALL and T-cell lymphoma led by LaQuisa Hill Center for Cell and Gene Therapy Very encouraging responses already, stay tuned for more updates 6/ clinicaltrials.gov/ct2/show/NCT03…

Max Mamonkin (@maxmamonkin) 's Twitter Profile Photo

Excited to share first results of unedited CD5 CAR T in r/r T-cell lymphoma from a trial led by LaQuisa Hill and R.Rouce Center for Cell and Gene Therapy Infusions were safe and responses durable, with 2 pts still in CR 5+ years later. Multicenter Phase 2 later this year. sciencedirect.com/science/articl…

Excited to share first results of unedited CD5 CAR T in r/r T-cell lymphoma from a trial led by <a href="/HillLaQuisa/">LaQuisa Hill</a> and R.Rouce <a href="/CAGTHouston/">Center for Cell and Gene Therapy</a> Infusions were safe and responses durable, with 2 pts still in CR 5+ years later. Multicenter Phase 2 later this year.  sciencedirect.com/science/articl…